Episode 24: The Pill Problem: Why America’s Medicine Cabinet is Made in China (and How We Fix It) with Rep. Buddy Carter
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
-
Letto da:
-
Di:
A proposito di questo titolo
Did you know that 90% of the antibiotics used in America depend on active ingredients made in China? 💊🇺🇸
In 2002, nearly 72% of the drugs consumed in the U.S. were made here. By 2023, that number plummeted to just 37.5%. We have offshored our national security, our health supply chain, and critical high-tech manufacturing jobs to adversarial nations.
In this urgent episode of The Made in America Hour, host Zach Mottl is joined by a man who knows the dangers firsthand: Congressman Earl "Buddy" Carter (R-GA), the only pharmacist currently serving in Congress. Along with John Toomey from the Coalition for a Prosperous America, they expose the terrifying reality of America’s dependence on China and India for our generic drugs and Active Pharmaceutical Ingredients (APIs).
We discuss how foreign control of our medicine supply is a loaded weapon that has already been used against us during the pandemic, the alarming quality control issues with overseas manufacturing, and why reshoring these industries won't spike inflation.
Tune in to hear:
🛑 The shocking statistics on how dependent the U.S. really is on foreign APIs.
🏭 How the "MADE in America Act" aims to bring pharmaceutical manufacturing—and high-paying jobs—back home.
🩺 Why the FDA struggles to inspect foreign facilities compared to American ones.
🇺🇸 The bipartisan push to secure our medical supply chain before the next crisis hits.
It’s time to stop outsourcing our health and start making medicine in America again.
👇 Listen now to understand the stakes and the solutions. 👇
#MadeInAmerica #Reshoring #SupplyChain #NationalSecurity #Healthcare #Pharma #ManufacturingJobs #RepBuddyCarter #CPA #Economics #Policy #China #India #GenericDrugs #API #AmericanManufacturing
Hosted on Ausha. See ausha.co/privacy-policy for more information.